Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1994-09-16
1995-10-10
Ramsuer, Robert W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514132, A61K 31535, C07D41306
Patent
active
054571073
ABSTRACT:
This invention is concerned with a novel polymorphic form of the compound 2-(S)-(3,5-bis(trifluoromethyl)benzyloxy)-4-(3-(5-oxo-1H,4H-1,2,4-triazolo )methyl)-3-(S)-phenyl-morpholine which is a tachykinin receptor antagonist useful in the treatment of inflammatory diseases, pain or migraine, asthma, and emesis.
The instant polymorphic form has advantages over the other known forms of 2-(S)-(3,5-bis(trifluoromethyl)benzyloxy)-4-(3-(5-oxo-1H,4H-1,2,4-triazolo )methyl)-3-(S)-phenyl-morpholine in terms of thermodynamic stability and suitability for inclusion in pharmaceutical formulations.
Merck & Co. , Inc.
Ramsuer Robert W.
Rose David L.
Thies J. Eric
LandOfFree
Polymorphic form of a tachykinin receptor antagonist does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polymorphic form of a tachykinin receptor antagonist, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polymorphic form of a tachykinin receptor antagonist will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2310560